CytoSorbents Corporation (CTSO)

[Aliberto]

A propensity score matching analysis

... Furthermore, there was no significant difference in the relative change in C-reactive protein, lactate, or norepinephrine demand in either group and the in-hospital mortality was similar between groups (73.7%). This small, heterogenous study showed no difference in IL-6 reduction, hemodynamic stabilization, or mortality in patients with CytoSorbtreatment compared to a matched patient population.